Am J Perinatol 2020; 37(09): 962-969
DOI: 10.1055/s-0039-1692184
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Therapeutic Plasma Exchange in Neonatal Septic Shock: A Retrospective Cohort Study

Taylor Sawyer
1   Division of Neonatology, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington
,
Zeenia Billimoria
1   Division of Neonatology, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington
,
Sarah Handley
1   Division of Neonatology, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington
,
Kendra Smith
1   Division of Neonatology, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington
,
Larissa Yalon
2   Extracorporeal Life Support Services, Seattle Children's Hospital, Seattle, Washington
,
Thomas V. Brogan
3   Division of Pediatric Critical Care, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington
,
Robert DiGeronimo
1   Division of Neonatology, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington
› Author Affiliations
Further Information

Publication History

26 March 2019

26 March 2019

Publication Date:
08 June 2019 (online)

Abstract

Objective This study aimed to examine the use of therapeutic plasma exchange (TPE) as adjunctive therapy in neonatal septic shock.

Study Design This retrospective cohort study was performed on a convenience sample of neonates in a quaternary children's hospital between January 2018 and February 2019.

Results We identified three neonates with septic shock who received TPE. Two neonates had adenovirus sepsis, and one had group B streptococcal sepsis. All neonates were on extracorporeal life support (ECLS) when TPE was started. The median duration of TPE was 6 days (interquartile range [IQR]: 3–15), with a median of four cycles (IQR: 3–5). Lactate levels decreased significantly after TPE (median before TPE: 5.4 mmol/L [IQR: 2.4–6.1] vs. median after TPE: 1.2 mmol/L [IQR: 1.0–5.8]; p < 0.001). Platelet levels did not change (median before TPE: 73,000/mm3 [IQR: 49,000–100,000] vs. median after TPE: 80,000/mm3 (IQR: 62,000–108,000); p = 0.2). Organ failure indices improved after TPE in two of the three neonates. Hypocalcemia was seen in all cases despite prophylactic calcium infusions. One neonate died, and two survived to ICU discharge.

Conclusion TPE can be safely performed in neonates with septic shock. TPE may have a role as an adjunctive therapy in neonates with septic shock requiring ECLS.

 
  • References

  • 1 Lawn JE, Cousens S, Zupan J. ; Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: when? Where? Why?. Lancet 2005; 365 (9462): 891-900
  • 2 Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003; 167 (05) 695-701
  • 3 Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. Lancet 2017; 390 (10104): 1770-1780
  • 4 Murphy DJ, Hope PL, Johnson A. Neonatal risk factors for cerebral palsy in very preterm babies: case-control study. BMJ 1997; 314 (7078): 404-408
  • 5 Stoll BJ, Hansen NI, Adams-Chapman I. , et al; National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292 (19) 2357-2365
  • 6 Shah DK, Doyle LW, Anderson PJ. , et al. Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imaging at term. J Pediatr 2008; 153 (02) 170-175
  • 7 Singer M, Deutschman CS, Seymour CW. , et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315 (08) 801-810
  • 8 Shankar-Hari M, Phillips G, Levy ML. , et al. Assessment of definition and clinical criteria for septic shock (Sepsis-3). JAMA 2016; 315 (08) 4
  • 9 Wynn JL, Wong HR. Pathophysiology and treatment of septic shock in neonates. Clin Perinatol 2010; 37 (02) 439-479
  • 10 Bone RC. The sepsis syndrome. Definition and general approach to management. Clin Chest Med 1996; 17 (02) 175-181
  • 11 Gupta N, Richter R, Robert S, Kong M. Viral sepsis in children. Front Pediatr 2018; 6: 252
  • 12 Rhodes A, Evans LE, Alhazzani W. , et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017; 43 (03) 304-377
  • 13 Du Pont-Thibodeau G, Joyal JS, Lacroix J. Management of neonatal sepsis in term newborns. F1000Prime Rep 2014; 6: 67
  • 14 Hanna W, Wong HR. Pediatric sepsis: challenges and adjunctive therapies. Crit Care Clin 2013; 29 (02) 203-222
  • 15 Vincent JL, Ramesh MK, Ernest D. , et al. A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med 2013; 41 (09) 2069-2079
  • 16 Levin M, Quint PA, Goldstein B. , et al. Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet 2000; 356 (9234): 961-967
  • 17 Brocklehurst P, Farrell B, King A. , et al; INIS Collaborative Group. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med 2011; 365 (13) 1201-1211
  • 18 Altit G, Vigny-Pau M, Barrington K, Dorval VG, Lapointe A. Corticosteroid Therapy in Neonatal Septic Shock-Do We Prevent Death?. Am J Perinatol 2018; 35 (02) 146-151
  • 19 Iwai H, Nagaki M, Naito T. , et al. Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit Care Med 1998; 26 (05) 873-876
  • 20 Nakamura T, Ushiyama C, Suzuki S. , et al. Effect of plasma exchange on serum tissue inhibitor of metalloproteinase 1 and cytokine concentrations in patients with fulminant hepatitis. Blood Purif 2000; 18 (01) 50-54
  • 21 Nguyen TC, Kiss JE, Goldman JR, Carcillo JA. The role of plasmapheresis in critical illness. Crit Care Clin 2012; 28 (03) 453-468 , vii
  • 22 Rothenberg T. Partial plasma exchange transfusion in polycythaemic neonates. Arch Dis Child 2002; 86 (01) 60-62
  • 23 Ozek E, Soll R, Schimmel MS. Partial exchange transfusion to prevent neurodevelopmental disability in infants with polycythemia. Cochrane Database Syst Rev 2010; 20 (01) CD005089
  • 24 Schwartz J, Padmanabhan A, Aqui N. , et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the Seventh Special Issue. J Clin Apher 2016; 31 (03) 149-162
  • 25 Ramsi M, Al Ali AS. Thrombocytopenia-associated multiple-organ failure (TAMOF): recognition and management. BMJ Case Rep 2018; 2018: pii : bcr-2018-225594
  • 26 Nguyen TC, Carcillo JA. Bench-to-bedside review: thrombocytopenia-associated multiple organ failure--a newly appreciated syndrome in the critically ill. Crit Care 2006; 10 (06) 235
  • 27 Rimmer E, Houston BL, Kumar A. , et al. The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis. Crit Care 2014; 18 (06) 699
  • 28 Zhou F, Peng Z, Murugan R, Kellum JA. Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med 2013; 41 (09) 2209-2220
  • 29 Reeves JH, Butt WW, Shann F. , et al; Plasmafiltration in Sepsis Study Group. Continuous plasmafiltration in sepsis syndrome. Crit Care Med 1999; 27 (10) 2096-2104
  • 30 Busund R, Koukline V, Utrobin U, Nedashkovsky E. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med 2002; 28 (10) 1434-1439
  • 31 Nguyen TC, Han YY, Kiss JE. , et al. Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med 2008; 36 (10) 2878-2887
  • 32 Long EJ, Taylor A, Delzoppo C. , et al. A randomised controlled trial of plasma filtration in severe paediatric sepsis. Crit Care Resusc 2013; 15 (03) 198-204
  • 33 Kawai Y, Cornell TT, Cooley EG. , et al. Therapeutic plasma exchange may improve hemodynamics and organ failure among children with sepsis-induced multiple organ dysfunction syndrome receiving extracorporeal life support. Pediatr Crit Care Med 2015; 16 (04) 366-374
  • 34 Doughty L, Carcillo JA, Kaplan S, Janosky J. The compensatory anti-inflammatory cytokine interleukin 10 response in pediatric sepsis-induced multiple organ failure. Chest 1998; 113 (06) 1625-1631
  • 35 Schmidt JJ, Asper F, Einecke G, Eden G, Hafer C, Kielstein JT. Therapeutic plasma exchange in a tertiary care center: 185 patients undergoing 912 treatments - a one-year retrospective analysis. BMC Nephrol 2018; 19 (01) 12
  • 36 Ronchi A, Doern C, Brock E, Pugni L, Sánchez PJ. Neonatal adenoviral infection: a seventeen year experience and review of the literature. J Pediatr 2014; 164 (03) 529-535
  • 37 Piedra PA. Adenovirus in the neonatal intensive care unit: formidable, forgotten foe. J Pediatr 2005; 146 (04) 447-448
  • 38 Faden H, Wynn RJ, Campagna L, Ryan RM. Outbreak of adenovirus type 30 in a neonatal intensive care unit. J Pediatr 2005; 146 (04) 523-527
  • 39 Vidal E, Garzotto F, Parolin M. , et al. Therapeutic plasma exchange in neonates and infants: successful use of a miniaturized machine. Blood Purif 2017; 44 (02) 100-105